Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 2(2)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05377853Not ApplicableUnknown

Advanced Spatiomotor Rehabilitation for Navigation in Blindness & Visual Impairment

Role: lead

NCT04423341Phase 2Completed

Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm

Role: collaborator

NCT02691156Completed

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

Role: collaborator

NCT01616108Phase 2Unknown

Bupivacaine Injection of Eye Muscles to Treat Strabismus

Role: lead

NCT01660620Phase 1Completed

Topical Betaxolol for the Prevention of Retinopathy of Prematurity

Role: lead

All 5 trials loaded